Clinical and economic analysis of pharmacotherapy of patients with toxic liver injury in Kharkiv hospitals
Keywords:clinical and economic analysis, pharmacotherapy of patients, toxic hepatitis
Topicality. Currently, toxic liver lesions are widely spread in the world and in Ukraine, with various causes and chronic course.
Aim. To make clinical and economic analysis (ABC and frequency analysis) of pharmacotherapy of patients with toxic hepatitis based on hepatotropic drugs with ATC code A05A and A05B.
Materials and methods. The medical charts of 55 patients with the main diagnosis of “toxic hepatitis” from Kharkiv hospitals have been used.
Results and discussion. A total of 134 drugs have been used from different pharmacotherapeutic groups, administered 552 times, 10 appointments per patient, indicating polypharmacy. It was spent 254739,27 UAH for pharmacotherapy of 55 patients. Group A included 26 drugs, spent UAH 204035,91 (80.10 %), group B included 38 tonnes of drugs for the amount of UAH 38099,92 (14.96 %), and group C – 70 tonnes of drugs for the amount of UAH 12603,44 (4.94 %). Group A included the most expendable drugs, among which the first positions were mostly expensive drugs: Heptral (16 appointments), Heparizine (15), Ornilov (14), Hepadiff (9), sodium chloride solution 0.9 % (55, cheap drug) and other drugs.Conclusions. Among the 134 drugs used for the pharmacotherapy of patients, 13 drugs of hepatotropic action and 5 drugs of amino acid composition with code A16AA, also used for the treatment of toxic hepatitis. The total amount of 128,875.88 UAH (50.59 %) has been spent for these 18 drugs, administered 272 times (49.28% of prescriptions).
Asrani, S. K., Devarbhavi, H., Eaton, J., & Kamath, P. S. (2019). Burden of liver diseases in the world. Journal of hepatology, 70 (1), 151–171. https://doi.org/10.1016/j.jhep.2018.09.014
Mao, W., Vu, H., Xie, Z., Chen, W., Tang, S. (2015). Systematic Review on Irrational Use of Medicines in China and Vietnam. PLoS ONE 10 (3), e0117710. https://doi.org/10.1371/journal.pone.0117710
Samootsinka naselenniam stanu zdorovia ta rivnia dostupnosti okremykh vydiv medychnoi dopomohy u 2018 rotsi. (2019). Derzhavna sluzhba statystyky. Available at: http://www.ukrstat.gov.ua/druk/publicat/kat_u/2019/ zb/03/zb_snsz2018pdf.pdf
Kleiner, D. E. (2017). Drug-induced Liver Injury: The Hepatic Pathologist’s Approach. Gastroenterology clinics of North America, 46 (2), 273–296. https://doi.org/10.1016/j.gtc.2017.01.004
Morozov, A. M., Yakovlieva, L. V., Bezditko, N. V. (2013). Otsinka klinichnoi ta ekonomichnoi dotsilnosti vykorystannia likarskykh zasobiv u likuvalno-profilaktychnomu zakladi (suprovid formuliarnoi systemy): metod. rek. Kharkiv, 36.
Copyright (c) 2020 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).